l-carnitin lebensmittel natürlich lang leben Base Pulver Buy L-Carnitine Capsules | 2050

Gastrointestinal adverse events Very common (10% or more): Diarrhea (35%), abdominal pain (21%), vomiting (21%), nausea (12%) Common (1% to 10%): Constipation, dyspepsia, gastrointestinal disorder, melena Very rare (less than 0.01%): Abdominal cramps [Ref] Nervous system Very common (10% or more): Headache (37%), dizziness (18%), paresthesia (12%) Common (1% to 10%): Hypertonia, vertigo, taste perversion Frequency not reported : Seizures (with or without pre-existing seizure activity), increase in seizure frequency and/or severity [Ref] Metabolic Very common (10% or more): Hypercalcemia (15%), hypervolemia (12%) Common (1% to 10%): Anorexia, hyperkalemia [Ref] There are reports from clinical trials of significant hypertriglyceridemia associated with high doses of levocarnitine (3 g/day) given to uremic dialysis patients

doi: 10.1016/j.clnu.2019.10.025 34

210 EAA/leucine supplementation in advanced lung cancer patients elicits anabolic responses, which favorably impact patient prognosis

The respective Market Authorization Holder of the product may petition the FDA for the lifting of this advisory by submitting a formal written request via e-mail at [email protected] or through physical correspondence